Understanding Cerebral Palsy: Causes, Types, Comorbidities, and Management
Definition
Cerebral palsy (CP) is a group of permanent movement and posture disorders attributed to non-progressive disturbances in the developing fetal/infant brain. Most common motor disability in childhood (prevalence ~2–3/1,000 live births).
Etiology (Timing of Insult)
- Prenatal (70–80%): Malformations, placental insufficiency, infection (TORCH), stroke, genetic syndromes, multiple gestation, prematurity (<32 wks, <1500 g).
- Perinatal (10–20%): Hypoxic-ischemic encephalopathy (HIE), birth trauma, kernicterus.
- Postnatal (<10%): Meningitis/encephalitis, stroke, TBI, near-drowning, abuse.
Classification
| Motor Type | Features | Distribution |
|---|---|---|
| Spastic (80%) | Velocity-dependent hypertonia, clonus, contractures | Hemiplegia, diplegia, quadriplegia |
| Dyskinetic (10–15%) | Dystonia, choreoathetosis; fluctuating tone | Often truncal/oral involvement |
| Ataxic (5%) | Hypotonia, intention tremor, gait instability | Global |
| Mixed | Combination (commonly spastic+dyskinetic) | Variable |
Gross Motor Function Classification System (GMFCS) levels I–V stratify functional mobility.
Associated Comorbidities
- Intellectual disability (~50%), epilepsy (~35%), speech/language disorders, visual/hearing impairment, hip displacement, scoliosis, GERD, constipation, sleep disorders, behavioral/mental health issues.
Diagnosis
- Clinical: history, motor exam, tone/reflexes, persistent primitive reflexes.
- Neuroimaging: MRI brain (preferred) – identifies etiology, timing, predicts severity.
- Genetic/metabolic testing if atypical presentation or family history.
Multidisciplinary Management
- Therapies: PT (mobility, orthotics, equipment), OT (ADLs, fine motor, assistive tech), SLP (communication, AAC, feeding/swallowing).
- Tone management: Oral baclofen, botulinum toxin injections, selective dorsal rhizotomy (SDR), intrathecal baclofen pump.
- Orthopedic surgery: Tendon releases, osteotomies, hip surveillance (Reimers index).
- Medical: Antiseizure meds, reflux/constipation management, tone-modulating drugs.
- Transition planning: Education, vocation, independent living, adult care transfer.
Prognosis & Quality of Life
Variable; many with GMFCS I–II live independently. Early intervention, family-centered care, and inclusion maximize participation. Life expectancy near normal for mild CP; reduced for severe (GMFCS V) due to respiratory/complication burden.
Neurological Disorders - Related Articles
- Down Syndrome and Lower Back Pain: Understanding the Connection
- Clindamycin & Seizure Risk: What the Evidence Shows
- Chemotherapy-Induced Peripheral Neuropathy (CIPN): Understanding Reflex Damage
- Intracranial Hypertension Support: Resources & Communities
- H1N1 Flu and Seizures: What You Need to Know
- Understanding Parkinson's Disease: Mortality & Key Symptoms
- MS Spinal Cord Symptoms: Understanding Weakness & Other Signs
